Delivery Order SPE2DB22D1200-SPE2DB24FN2VB
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S over a period ending on April 16, 2024. The contract, valued at $2,213.85, was awarded by the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, with a ceiling value of $1,177.41 and a completion date of May 19, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,344.97, is a firm fixed-price delivery order with a completion date of January 30, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The $1,400.64 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,198.16 and a completion date of September 5, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of...
- This federal contract award is for the delivery of 4,565,696,250 units of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,750.80 and was awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 6, 2024. No set-aside was used for this award. Amerisourcebergen is a major supplier of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract, valued at $2,370.73, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 13, 2023. No set-aside designation was used for this award. Amerisourcebergen holds a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. This $1,349.70 award has a completion date of February 7, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- This federal contract award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The $2,173.68 firm fixed-price contract was awarded on December 31, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 2, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN2VBDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,193.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award is not set-aside and was likely made on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/30/24 |